hunter williams retatrutide The Tesamorelin Masterclass | The Complete User's Guide (2026) - The Podcast Welcome! Here's What You Need

following 48 training days, the response requirement was incrementally increased by two (to FR6, FR8, etc.), until 8 consecutive days of responding at FR10

Its long half-life means once-weekly dosing maintains stable blood levels, which is ideal both for efficacy and patient adherence

Communication with the patients care team, including primary care providers and endocrinologists, is essential

In the Phase 2 trial, weight loss continued at 48 weeks across all dose groups, suggesting retatrutide may not plateau as single-receptor medications often do

I had him on a weight-based biologic infusion and even that wasnt giving him adequate control

Doi:10.1056/NEJMoa2307563 Wilding JPH, et al